par de Castro, Gilberto;Awada, Ahmad 
Référence Current opinion in oncology, 18, 4, page (307-315)
Publication Publié, 2006-07

Référence Current opinion in oncology, 18, 4, page (307-315)
Publication Publié, 2006-07
Article révisé par les pairs
Titre: |
|
Auteur: | de Castro, Gilberto; Awada, Ahmad |
Informations sur la publication: | Current opinion in oncology, 18, 4, page (307-315) |
Statut de publication: | Publié, 2006-07 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Anti-angiogenic agents |
Bortezomib | |
Farnesyltransferase inhibitors | |
Lenalidomide | |
Molecular-targeted therapies | |
Tyrosine-kinase inhibitors | |
MeSH keywords: | Antineoplastic Agents -- adverse effects |
Boronic Acids -- adverse effects | |
Drug Design | |
Farnesyltranstransferase -- antagonists & inhibitors | |
Humans | |
Immunologic Factors -- adverse effects | |
Neoplasms -- therapy | |
Protease Inhibitors -- pharmacology | |
Proteasome Endopeptidase Complex -- metabolism | |
Protein-Tyrosine Kinases -- antagonists & inhibitors | |
Pyrazines -- adverse effects | |
Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors | |
Thalidomide -- adverse effects | |
Thalidomide -- analogs & derivatives | |
Note générale: | Journal Article |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:1040-8746 |
info:doi/10.1097/01.cco.0000228733.55132.ea | |
info:pii/00001622-200607000-00002 | |
info:scp/33748079780 | |
info:pmid/16721122 |